Possible COVID Breakthrough: Israeli Ministry of Health Approves Extension of Israeli Drug Trial at Rambam Medical Center to Other Israel Hospitals
August 11, 2021 – The Israeli Ministry of Health confirmed that hospitals will begin treating critically ill COVID-19 patients with a new Israeli drug called “MesenCure“ manufactured by Bonus BioGroup. The decision was made after recent clinical trials with the experimental drug at Rambam, with good results: 14 out of 16 seriously ill COVID-19 patients…